Form 4: Zoetis Inc. Director Mark Stetter Reports Acquisition of Restricted Stock Units

Director Mark Stetter reports acquisition of 1,548 restricted stock units (RSUs) of Zoetis Inc. on May 21, 2025, vesting on the first anniversary.

Summary

• Mark Stetter, a director of Zoetis Inc., filed a Form 4 on May 22, 2025, reporting a transaction.
• On May 21, 2025, Stetter acquired 1,548 restricted stock units (RSUs) at a price of $161.44.
• These RSUs will vest and be settled in shares of Zoetis Inc. common stock on May 21, 2025, contingent upon continued service.
• The RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns director interests with shareholder value.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs will vest on May 21, 2025, subject to the reporting person's continued service.

Industry Context

This filing is a routine disclosure of equity-based compensation for a company director, common in publicly traded companies to align management interests with shareholder value.

Comparison to Industry Standards

• Equity compensation is a standard practice among publicly traded companies like Zoetis, with companies such as Elanco Animal Health and Merck Animal Health also utilizing stock options and restricted stock units as part of their compensation packages.
• The vesting schedules and terms of these grants are generally aligned with industry norms to incentivize long-term performance and retention.

Stakeholder Impact

• The granting of RSUs aligns the director's interests with those of the shareholders, incentivizing long-term value creation.

Key Dates

Keywords

Zoetis Inc., Mark Stetter, Restricted Stock Units, RSU, Form 4, Director, Equity and Incentive Plan, Beneficial Ownership